Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

OLSALAZINE SODIUM FOR PERFORMANCE TEST CRS (60 MG)

OLSALAZINE SODIUM FOR PERFORMANCE TEST CRS (60 MG)

6054-98-4

DISCOVER
OMEPRAZOLE CRS (50 MG)

OMEPRAZOLE CRS (50 MG)

73590-58-6

DISCOVER
OMEPRAZOLE IMPURITY D CRS (15MG)

OMEPRAZOLE IMPURITY D CRS (15MG)

88546-55-8

DISCOVER
Oxyphenbutazone hydrate

Oxyphenbutazone hydrate

7081-38-1

DISCOVER
Oxytetracycline 2H2O

Oxytetracycline 2H2O

6153-64-6

DISCOVER
ORCIPRENALINE SULFATE CRS (100 MG)

ORCIPRENALINE SULFATE CRS (100 MG)

5874-97-5

DISCOVER
Oxolinic acid

Oxolinic acid

14698-29-4

DISCOVER
OUABAIN CRS (150 MG)

OUABAIN CRS (150 MG)

11018-89-6

DISCOVER
OXAZEPAM CRS - * PSY (50 MG)

OXAZEPAM CRS - * PSY (50 MG)

604-75-1

DISCOVER
OXFENDAZOLE CRS (50 MG)

OXFENDAZOLE CRS (50 MG)

53716-50-0

DISCOVER
Oxytetracycline HCl

Oxytetracycline HCl

2058-46-0

DISCOVER
OXOLINIC ACID CRS (50 MG)

OXOLINIC ACID CRS (50 MG)

14698-29-4

DISCOVER